Arrowhead Pharmaceuticals
ARWR
#2176
Rank
HK$66.12 B
Marketcap
HK$478.29
Share price
-4.98%
Change (1 day)
175.62%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : HK$6.70 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total liabilities are HK$6.70 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Arrowhead Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30HK$7.37 B96.87%
2023-09-30HK$3.74 B74.43%
2022-09-30HK$2.14 B-8.46%
2021-09-30HK$2.34 B398.53%
2020-09-30HK$0.47 B-43.26%
2019-09-30HK$0.82 B547.24%
2018-09-30HK$0.12 B-29.14%
2017-09-30HK$0.18 B-29.67%
2016-09-30HK$0.25 B46.51%
2015-09-30HK$0.17 B34.29%
2014-09-30HK$0.13 B45.33%
2013-09-30HK$89.92 M50.25%
2012-09-30HK$59.84 M131.08%
2011-09-30HK$25.89 M-21.95%
2010-09-30HK$33.18 M50.54%
2009-09-30HK$22.04 M-42.7%
2008-09-30HK$38.46 M45.78%
2007-09-30HK$26.38 M15.97%
2006-09-30HK$22.75 M186.34%
2005-09-30HK$7.94 M47.8%
2004-09-30HK$5.37 M621.26%
2003-09-30HK$0.74 M-94.08%
2002-09-30HK$12.59 M19.52%
2001-09-30HK$10.53 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Alnylam Pharmaceuticals
ALNY
HK$35.94 B 436.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$4.09 B-38.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
HK$0.60 B-91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$883.85 B 13,089.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
HK$21.83 B 225.86%๐Ÿ‡บ๐Ÿ‡ธ USA